Roisin Mooney1, Pierluigi Simonato2, Risha Ruparelia1,3, Andres Roman-Urrestarazu4, Giovanni Martinotti5, Ornella Corazza6. 1. Psychology Department, University of Hertfordshire, Hatfield, UK. 2. School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK. 3. Hertfordshire Partnership University NHS Foundation Trust, Hatfield, UK. 4. Institute of Public Health (IPH), University of Cambridge, Cambridge, UK. 5. Department of Neuroscience, Imaging, Clinical Sciences, University "G. d''Annunzio" Chieti - Pescara, Chieti, Italy. 6. University Hertfordshire, Hatfield, UK.
Abstract
OBJECTIVE: The strive for perfection is prevalent in the fitness industry. This study aimed to explore the use of products to enhance performance alongside exposure to exercise addiction, appearance anxiety and self-esteem in fitness settings. METHODS: An online survey was prepared and piloted before wider dissemination in fitness clubs via snowballing and selected mailing lists. A list of commonly used products, including Performance and Image Enhancing Drugs (PIEDs) was provided. Exercise addiction (Exercise Addiction Inventory; EAI), anxiety levels (Appearance Anxiety Inventory; AAI) and their self-esteem (Rosenberg's Self-Esteem Scale; RSE) were also measured. RESULTS: 377 questionnaires were completed. A significant number of participants declared the use products either to lose weight (16%) or to reach their fitness goals (41%). The Internet played a major role in both the supply of information and the provision of the enhancement products (33.7%) and side effects were reported (10.5%). Only a limited number of participants sought a medical opinion about taking products (5.1%). EAI scores were high (m=20.02 ± 4.1), AAI (m=15.98 ± 4.8) showed an intermediate level of anxiety, while self-esteem was low (RSE m=12.59 ± 2.2). CONCLUSION: This pilot study identified the emergence of a new drug trend in fitness settings and showed a potential relationship to exercise addiction, anxiety disorders and low self-esteem. The Internet played a crucial role in disseminating often untested products, including PIEDs without medical supervision and unwanted side-effects were reported. More studies in the field are required in order to safeguard public health and inform policy making.
OBJECTIVE: The strive for perfection is prevalent in the fitness industry. This study aimed to explore the use of products to enhance performance alongside exposure to exercise addiction, appearance anxiety and self-esteem in fitness settings. METHODS: An online survey was prepared and piloted before wider dissemination in fitness clubs via snowballing and selected mailing lists. A list of commonly used products, including Performance and Image Enhancing Drugs (PIEDs) was provided. Exercise addiction (Exercise Addiction Inventory; EAI), anxiety levels (Appearance Anxiety Inventory; AAI) and their self-esteem (Rosenberg's Self-Esteem Scale; RSE) were also measured. RESULTS: 377 questionnaires were completed. A significant number of participants declared the use products either to lose weight (16%) or to reach their fitness goals (41%). The Internet played a major role in both the supply of information and the provision of the enhancement products (33.7%) and side effects were reported (10.5%). Only a limited number of participants sought a medical opinion about taking products (5.1%). EAI scores were high (m=20.02 ± 4.1), AAI (m=15.98 ± 4.8) showed an intermediate level of anxiety, while self-esteem was low (RSE m=12.59 ± 2.2). CONCLUSION: This pilot study identified the emergence of a new drug trend in fitness settings and showed a potential relationship to exercise addiction, anxiety disorders and low self-esteem. The Internet played a crucial role in disseminating often untested products, including PIEDs without medical supervision and unwanted side-effects were reported. More studies in the field are required in order to safeguard public health and inform policy making.
Authors: Valeria Catalani; Mariya Prilutskaya; Ahmed Al-Imam; Shanna Marrinan; Yasmine Elgharably; Mire Zloh; Giovanni Martinotti; Robert Chilcott; Ornella Corazza Journal: Brain Sci Date: 2018-02-20
Authors: Ornella Corazza; Pierluigi Simonato; Zsolt Demetrovics; Roisin Mooney; Katinka van de Ven; Andres Roman-Urrestarazu; Lili Rácmolnár; Ilaria De Luca; Eduardo Cinosi; Rita Santacroce; Massimo Marini; David Wellsted; Keith Sullivan; Giuseppe Bersani; Giovanni Martinotti Journal: PLoS One Date: 2019-04-03 Impact factor: 3.240
Authors: Franca Ceci; Francesco Di Carlo; Julius Burkauskas; Anatolia Salone; Ilaria De Luca; Dorotea Cicconcelli; Valentina Giorgetti; Irene La Fratta; Antonino Todaro; Pierluigi Simonato; Giovanni Martinotti; Massimo di Giannantonio; Ornella Corazza Journal: Int J Ment Health Addict Date: 2022-04-20 Impact factor: 11.555
Authors: Mami Shibata; Julius Burkauskas; Artemisa R Dores; Kei Kobayashi; Sayaka Yoshimura; Pierluigi Simonato; Ilaria De Luca; Dorotea Cicconcelli; Valentina Giorgetti; Irene P Carvalho; Fernando Barbosa; Cristina Monteiro; Toshiya Murai; Maria A Gómez-Martínez; Zsolt Demetrovics; Krisztina Edina Ábel; Attila Szabo; Alejandra Rebeca Melero Ventola; Eva Maria Arroyo-Anlló; Ricardo M Santos-Labrador; Inga Griskova-Bulanova; Aiste Pranckeviciene; Giuseppe Bersani; Hironobu Fujiwara; Ornella Corazza Journal: Front Psychol Date: 2021-07-06
Authors: Leticia Olave; Ana Estévez; Janire Momeñe; Roger Muñoz-Navarro; María José Gómez-Romero; María Jesús Boticario; Itziar Iruarrizaga Journal: Front Psychol Date: 2021-06-18